China Universal Asset Management Company’s Enliven Therapeutics ELVN Stock Holding History

China Universal Asset Management Company’s Portfolio ELVN Stock Details ELVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$198K	Buy
2025 Q1	$193K	Sell
2024 Q4	$233K	Buy
2024 Q3	$232K	Buy
2024 Q2	$129K	Sell
2024 Q1	$140K	Buy
2023 Q4	$65.9K	Buy